Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies

Epigenetics

Volumn 4, Issue 7, 2009, Pages 469-475

  Katrincsakova, Beata ^a,b,c   Takeda, Haruko ^c   Urbankova, Helena ^a,b   Michaux, Lucienne ^a   Jarosova, Marie ^b   Vandenberghe, Peter ^a   Georges, Michel ^c   Charlier, Carole ^c   Wlodarska, Iwona ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Deletion; DLK1 GTL2; Immunoglobulin heavy chain locus; Imprinted genes; microRNA; Tumor suppressor gene

Indexed keywords

CHROMOSOME PROTEIN; DLK1 GTL2 PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CHROMOSOME 14Q; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE INACTIVATION; GENOME IMPRINTING; HUMAN; INTERSTITIAL CHROMOSOME DELETION; LARGE CELL LYMPHOMA; METHYLATION; NONHODGKIN LYMPHOMA; PROLYMPHOCYTIC LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; WALDENSTROEM MACROGLOBULINEMIA;

EID: 73449096760     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.4.7.9924     Document Type: Article

References (25)

1. Pospisilova H, Baens M, Michaux L, Stul M, Van Hummelen P, Van Loo P, et al. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007; 21:2079-83.
2. Debiec-Rychter M, Sciot R, Pauwels P, Schoenmakers E, Dal Cin P, Hagemeijer A. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors. Genes Chromosomes Cancer 2001; 32:26-32.
3. Wylie AA, Murphy SK, Orton TC, Jirtle RL. Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res 2000; 10:1711-8.
4. miRBase [database on the Internet]. Wellcome Trust Sanger Institute, Hinxton Cambridge UK. [cited 10-9-2008]. Available from: http://microrna.sanger. ac.uk.
5. Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, et al. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12 Nat Genet 2003; 35:97-102.
6. Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, et al. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005; 92:1574-80.
7. Sakajiri S, O'kelly J, Yin D, Miller CW, Hofmann WK, Oshimi K, et al. Dlk1 in normal and abnormal hematopoiesis. Leukemia 2005; 19:1404-10.
8. Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet 2006; 15:821-30.
9. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by MEG3 noncoding RNA. J Biol Chem 2007; 282:24731-42.
10. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, et al. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008; 93:4119-25.
11. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaillé J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 2004; 14:1741-8.
12. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008; 105:7004-9.
13. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9:435-43.
14. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008; 27:378-86.
15. Dalmay T. MicroRNAs and cancer. J Intern Med 2008; 263:366-75.
16. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008; 22:1095-105.
17. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99:15524-9.
18. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353:1793-801.
19. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27:2240-52.
20. Paige AJ. Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Cell Mol Life Sci 2003; 60:2147-63.
21. Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 2007; 315:642-5.
22. Sherry ST, Ward M, Sirotkin K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 1999; 9:677-9. Available from: http://www.ncbi.nlm.nih.gov/SNP.
23. Ge B, Gurd S, Gaudin T, Dore C, Lepage P, Harmsen E, et al. Survey of allelic expression using EST mining. Genome Res 2005; 15:1584-91.
24. Takeda H, Caiment F, Smit M, Hiard S, Tordoir X, Cockett N, et al. The callipyge mutation enhances bidirectional long-range DLK1-GTL2 intergenic transcription in cis. Proc Natl Acad Sci USA 2006; 103:8119-24.
25. Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2005; 137:12-23.